創傷管理用バイオマテリアルの米国市場

Market Highlights

The US market for wound management biomaterials, consisting of internal tissue sealants, surgical hemostats, and adhesion barriers, was valued at nearly $500 million in 2003, with a market value over $520 expected by the end of 2004. By 2009, the biomaterials market will grow at over $880 million.

Leading growth will be the market for adhesion barriers, which will benefit from the potential for a growing number fo clinical indications, such as cardiac surgery.

MRGs US Markets for Wound Management Biomaterials 2004 provides unsurpassed segmentation providing indepth information on this explosive industry.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 MARKET OVERVIEW

1.1 Market Overview

1.2 Product Overview

1.3 Market Drivers

1.4 Market Limiters

1.5 Competitive Analysis

2.0 INTERNAL TISSUE SEALANTS MARKET

2.1 Market Overview

2.2 Product Overview

2.3 Procedure Overview

2.4 Fibrin-Based Sealants

2.4.1 Market Analysis

2.5 Protein-Based Sealants

2.5.1 Market Analysis

2.6 Synthetic-Based Sealants

2.6.1 Market Analysis

2.7 Market Drivers and Limiters

2.7.1 Market Drivers

2.7.2 Market Limiters

2.8 Competitive Analysis

2.9 Products in Development

2.9.1 3M Corporation

2.9.2 Cohesion Technologies (Angiotech Pharmaceuticals)

2.9.3 Closure Medical

2.9.4 Confluent Surgical

2.9.5 Haemacure

2.9.6 Surgical Specialties Inc

3.0 SURGICAL HEMOSTATS MARKET

3.1 Market Overview

3.2 Product Overview

3.3 Thrombin-Based Hemostats

3.3.1 Market Analysis.

3.4 Oxidized Regenerated Cellulose-Based Hemostats

3.4.1 Market Analysis

3.5 Gelatin-Based Hemostats

3.5.1 Market Analysis

3.6 Combination Hemostats

3.6.1 Market Analysis

3.7 Collagen-Based Hemostats

3.7.1 Market Analysis

3.8 Autologous-Based Hemostats

3.8.1 Market Analysis

3.9 Polysaccharide-Based Hemostats

3.9.1 Market Analysis

3.10 Market Drivers and Limiters

3.10.1 Market Drivers

3.10.2 Market Limiters

3.11 Competitive Analysis

3.12 First Responder Hemostats

3.12.1 Medafor Inc.

3.12.2 Z-Medica

3.13 Products in Development

3.13.1 Medafor Inc.

4.0 ADHESION BARRIERS MARKET

4.1 Market Overview

4.2 Adhesion Formation Overview

4.3 Product Overview

4.3.1 Films

4.3.2 Gels

4.4 Procedure Overview

4.5 Market Analysis

4.6 Market Drivers and Limiters

4.6.1 Market Drivers

4.6.2 Market Limiters

4.7 Competitive Analysis

4.8 Products In Development

4.8.1 Alliance Pharmaceuticals/Reeve Consulting

4.8.2 Cohesion Technologies (Angiotech Pharmaceuticals)

4.8.3 Confluent Surgical

4.8.4 FzioMed

4.8.5 Genzyme

4.8.6 Life Medical Sciences

APPENDIX A: ACRONYMS AND INITIALISMS

List of Exhibits

Exhibit ES-1: Wound Management Biomaterials Market, by Segment, US, 2003 ES-

Exhibit ES-2: Product Life Cycle for Internal Tissue Sealant Products, US, 2004 ES-

Exhibit ES-3: Thrombin-Based Hemostat Segment ASPs, US, 2003-009 ES-

Exhibit ES-4: Unit and ASP Growth, Adhesion Barriers Market, US, 2004-009 ES-

Exhibit ES-5: Leading Competitors in the Wound Management Biomaterials Market, US, 2003 ES-

Exhibit 1-1: Wound Management Biomaterials Market, by Segment, US, 2003-009 (Graphical Format)

Exhibit 1-2: Wound Management Biomaterials Market, by Segment, US, 2003-009 (Tabular Format)

Exhibit 1-3: Wound Management Biomaterials Market, US, 2003-009

Exhibit 1-4: Wound Management Biomaterials Market Segments and Related Products, US, 2003

Exhibit 1-5: Drivers and Limiters for the Wound Management Biomaterials Market, US, 2003-009

Exhibit 1-6: Annual Postoperative Complication Statistics, US, 2003

Exhibit 1-7: Leading Competitors in the Wound Management Biomaterials Market, by Segment, US, 2003 (Tabular Format)

Exhibit 1-8: Leading Competitors in the Wound Management Biomaterials Market, US, 2003 (Graphical Format)

Exhibit 2-1: Internal Tissue Sealants Market, US, 2003-009 (Graphical Format)

Exhibit 2-2: Internal Tissue Sealants Market, US, 2003-009 (Tabular Format)

Exhibit 2-3: Internal Tissue Sealants Market Segment Overview, US, 2003

Exhibit 2-4: Product Life Cycle for Internal Tissue Sealant Products, US, 2004

Exhibit 2-5: Selected Internal Tissue Sealant Procedures, US, 2003-009

Exhibit 2-6: Fibrin-Based Sealant Market, US, 2003-009

Exhibit 2-7: Protein-Based Sealant Market, US, 2003-009

Exhibit 2-8: Synthetic-Based Sealant Market, US, 2003-009

Exhibit 2-9: Drivers and Limiters for the Internal Tissue Sealants Market, US, 2003-009

Exhibit 2-10: Leading Competitors in the Internal Tissue Sealants Market, US, 2003

Exhibit 3-1: Surgical Hemostats Market, US, 2003-009 (Graphical Format)

Exhibit 3-2: Surgical Hemostats Market, US, 2003-009 (Tabular Format)

Exhibit 3-3: Surgical Hemostats Product Overview, US, 2003

Exhibit 3-4: Thrombin-Based Hemostat Market, US, 2003-009

Exhibit 3-5: Oxidized Regenerated Cellulose-Based Hemostat Market, US, 2003-009

Exhibit 3-6: Gelatin-Based Hemostat Market, US, 2003-009

Exhibit 3-7: Combination Hemostat Market, US, 2003-009

Exhibit 3-8: Collagen-Based Hemostat Market, US, 2003-009

Exhibit 3-9: Autologous-Based Hemostat Market, US, 2003-009

Exhibit 3-10: Polysaccharide-Based Hemostat Market, US, 2003-009

Exhibit 3-11: Drivers and Limiters for Surgical Hemostats, US, 2003-009

Exhibit 3-12: Surgical Hemostat ASPs, US, 2003 and 2009

Exhibit 3-13: Prophylactic Use of Internal Tissue Sealants, the Process, US, 2003

Exhibit 3-14: Leading Competitors in the Surgical Hemostats Market, US, 2003

Exhibit 4-1: Adhesion Barriers Market, US, 2003-009 (Graphical Format)

Exhibit 4-2: Selected Adhesion Barrier Procedures, US, 2003-009

Exhibit 4-3: Adhesion Barriers Market, US, 2003-009 (Tabular Format)

Exhibit 4-4: Drivers and Limiters for the Adhesion Barriers Market, US, 2003-009

Exhibit 4-5: Leading Competitors in the Adhesion Barriers Market, US, 2003